by CheckRare Staff | Aug 1, 2024
« Prev1 / 1Next »CTCL: Shortening the Diagnostic Journey and Starting Treatment Early (Full Interview)CTCL Overview (Chapter 1)Treatment Plans for CTCL (Chapter 2)CTCL: The Role of the Dermatologist in Caring for Patients (Chapter 3)Global Care...
by CheckRare Staff | Jul 26, 2024
« Prev1 / 1Next »CTCL: The Role of Dermatologists in Diagnosing and Caring for Patients (Full Interview)Challenges of Diagnosing CTCL (Chapter 1)The Role of the Dermatologist in Diagnosing and Caring for CTCL Patients (Chapter 2)Ensuring the Patient Is at...
by CheckRare Staff | Jun 1, 2024
Henry Kaminski, MD, Professor of Medicine at The George Washington University describes the early symptoms of myasthenia gravis (MG). MG is a chronic autoimmune neuromuscular disease characterized by weakness of the skeletal muscles. Common symptoms...
by CheckRare Staff | May 10, 2024
Katie Abouzahr, MD, Vice President, Autoantibody Portfolio and Maternal Fetal Disease Area Leader at Johnson & Johnson, discusses nipocalimab for the treatment of myasthenia gravis and other autoantibody diseases. Myasthenia gravis (MG) is a chronic...
by CheckRare Staff | Feb 26, 2024
Tyler Sandahl, PharmD, Clinical Pharmacist at the Mayo Clinic, discusses the use of tocilizumab in multiple myeloma patients. Multiple myeloma is a cancer that occurs due to abnormal, uncontrolled growth of plasma cells in the bone marrow. The most...
